SCHEMBL4582309

SCHEMBL4582309

CC1CC=C(C(C)C)CC1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21333674 0.85
SCHEMBL21333676 0.85
SCHEMBL4738702 0.85
SCHEMBL9188325 0.84
SCHEMBL11599880 0.83
SCHEMBL16646416 0.82
SCHEMBL22832069 0.81
SCHEMBL1532222 0.80
SCHEMBL8438958 0.78
SCHEMBL18517325 0.77 BACE1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 258 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4674922-A2 COMPOSITIONS COMPRISING 2,3,3,3-TETRAFLUOROPROPENE AND OXIDATION PRODUCTS The Chemours Company FC, LLC (US) 2026-01-07 EP claimed
US-20250325463-A1 COMPOSITIONS (III) SYMRISE AG (DE) 2025-10-23 US claimed
US-20250290009-A1 NEW LOW SULFUR TERPENE MIX RECOVERY FROM WOOD PROCESSING FIRMENICH SA (CH) 2025-09-18 US claimed
EP-4602141-A1 A FRAGRANCE MIXTURE (VI) Symrise AG (DE) 2025-08-20 EP claimed
CN-119930395-A Synthesis method of marjoram alcohol 江苏宏邦化工科技有限公司 2025-05-06 CN claimed
EP-4532646-A1 A FRAGRANCE MIXTURE (V) Symrise AG (DE) 2025-04-09 EP claimed
US-20250099349-A1 A FRAGRANCE MIXTURE SYMRISE AG (DE) 2025-03-27 US claimed
EP-4522714-A1 NEW LOW SULFUR TERPENE MIX RECOVERY FROM WOOD PROCESSING Firmenich SA (CH) 2025-03-19 EP claimed
CN-119654316-A Thioglutarimide isoindolinone skeleton-based compound and application thereof 标新生物医药科技(上海)有限公司 2025-03-18 CN claimed
EP-4519403-A1 A FRAGRANCE MIXTURE (V) Symrise AG (DE) 2025-03-12 EP claimed
WO-2016049398-A1 FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 WO claimed
US-20130338403-A1 NOVEL ALICYCLIC ALCOHOL MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2013-12-19 US claimed
EP-2660233-A1 NOVEL ALICYCLIC ALCOHOL Mitsubishi Gas Chemical Company, Inc. (JP) 2013-11-06 EP claimed
CN-101691542-A Muscodor endophytic fungi, application thereof and bactericide JIANDE DAYANG CHEMICAL CO LTD 2010-04-07 CN claimed
US-20080032913-A1 Masking of mineral oil odor and fragrancing of mineral oils SYMRISE GMBH & CO. KG (DE) 2008-02-07 US claimed
EP-1884555-A2 Masking mineral oil smell and scenting of mineral oils Symrise GmbH & Co. KG (DE) 2008-02-06 EP claimed
US-20040077063-A1 Process for the preparation of perillyl alcohol EIDGENOSSISCHE TECHNISCHE HOCHSCHULE ZURICH (CH) 2004-04-22 US claimed
EP-1364039-A1 PROCESS FOR THE PREPARATION OF PERILLYL ALCOHOL Eidgenössische Technische Hochschule Zürich (CH) 2003-11-26 EP claimed
EP-1236802-A1 Process for the preparation of perillyl alcohol AVENTIS ANIMAL NUTRITION S.A. (FR) 2002-09-04 EP claimed
WO-2002066662-A1 PROCESS FOR THE PREPARATION OF PERILLYL ALCOHOL Eidgenössische Technische Hochschule Zürich (CH) 2002-08-29 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250099349-A1 A FRAGRANCE MIXTURE PTMS, EP300, TRPA1 PTPN1 1042/4885
US-20130338403-A1 NOVEL ALICYCLIC ALCOHOL FIP1L1, FABP1, ADH1A PTPN1 4761/4885
US-20250325463-A1 COMPOSITIONS (III) NISCH, TAS1R3, TAS2R3 PTPN1 2530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.